Stimulation of ANP secretion by 2-Cl-IB-MECA through A3 receptor and CaMKII

Peptides

Volumn 29, Issue 12, 2008, Pages 2216-2224

  Yuan, Kuichang ^a   Bai, Guang Yi ^a   Park, Woo Hyun ^a   Kim, Sung Zoo ^a   Kim, Suhn Hee ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

A3 receptor; Adenosine; Atrial contractility; Atrial natriuretic peptide; cAMP; Purinoceptor; Signal transduction

Indexed keywords

2 CHLORO N (3 IODOBENZYL)ADENOSINE 5' N METHYLURONAMIDE; 6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLCARBOXAMIDE; ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR AGONIST; ADENOSINE A3 RECEPTOR ANTAGONIST; ADENYLATE CYCLASE; ATRIAL NATRIURETIC FACTOR; CALCIUM CHANNEL L TYPE; CYCLIC AMP; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; PHOSPHOLIPASE C; PROTEIN KINASE (CALCIUM,CALMODULIN) II; RYANODINE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; EXTRACELLULAR FLUID; HEART ATRIUM CONTRACTILITY; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FUNCTION; INOTROPISM; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN SECRETION; RAT; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION;

ADENOSINE; ANIMALS; ATRIAL NATRIURETIC FACTOR; CALCIUM; CALCIUM CHANNELS, L-TYPE; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CYCLIC AMP; EXTRACELLULAR FLUID; HEART ATRIA; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MALE; MYOCARDIAL CONTRACTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A3; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; TYPE C PHOSPHOLIPASES;

RATTUS;

EID: 55949128308     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.09.003     Document Type: Article

References (37)

1. 3 receptors in rat brain. Mol Pharmacol 48 (1995) 1038-1045
2. 6-(3-iodobenzyl) adenosine-5′-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits. Circ Res 80 (1997) 800-809
3. 3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs. Am J Physiol 285 (2003) H607-H613
4. Cho K.W., Seul K.H., Ryu H., Kim S.H., and Koh G.Y. Characteristics of distension-induced release of immunoreactive atrial natriuretic peptide in isolated perfused rabbit atria. Regul Pept 22 (1988) 333-345
5. Cho K.W., Seul K.H., Kim S.H., Koh G.Y., Seul K.M., and Hwang Y.H. Sequential mechanism of atrial natriuretic peptide secretion in isolated perfused rabbit atria. Biochem Biophys Res Commun 172 (1990) 423-431
6. Cho K.W., Kim S.H., Kim C.H., and Seul K.H. Mechanical basis of ANP secretion in beating atria: atrial stroke volume and ECF translocation. Am J Physiol 268 (1995) R1129-R1136
7. Cross H.R., Murphy E., Black R.G., Auchampach J., and Steenbergen C. Overexpression of A(3) adenosine receptors decreases heart rate, preserves energetics, and protects ischemic hearts. Am J Physiol Heart Circ Physiol 283 (2002) H1562-H1568
8. Cui X., Lee S.J., Kim S.Z., Kim S.H., and Cho K.W. Effects of pituitary adenylate cyclase activating polypeptide27 on cyclic AMP efflux and atrial dynamics in perfused beating atria. Eur J Pharmacol 402 (2000) 129-137
9. Ezeamuzie C.I., and Phillips E. Positive coupling of atypical adenosine A3 receptors on human eosinophils to adenylyl cyclase. Biochem Biophys Res Commun 300 (2003) 712-718
10. Gan X.T., Rajapurohitam V., Haist J.V., Chidiac P., Cook M.A., and Karmazyn M. Inhibition of phenylephrine-induced cardiomyocyte hypertrophy by activation of multiple adenosine receptor subtypes. J Pharmacol Exp Ther 312 (2005) 27-34
11. Ghelardoni S., Frascarelli S., Carnicelli V., Ronca-Testoni S., and Zucchi R. Modulation of cardiac sarcoplasmic reticulum calcium release by adenosine: a protein kinase C-dependent pathway. Mol Cell Biochem 288 (2006) 59-64
12. Goldenberg I., Shainberg A., Jacobson K.A., Shneyvays V., and Grossman E. Adenosine protects against angiotensin II-induced apoptosis in rat cardiocyte cultures. Mol Cell Biochem 252 (2003) 133-139
13. Han J.H., Cao C., Kim S.C., Cho K.W., and Kim S.H. Decreases in ANP secretion by lysophosphatidylcholine through protein kinase C. Hypertension 41 (2003) 1380-1385
14. Horio T., Nishikimi T., Yoshihara F., Matsuo H., Takishita S., and Kanagawa K. Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes. Hypertension 35 (2000) 19-24
15. Irons C.E., Sei C.A., Hidaka H., and Glembotski C.C. Protein kinase C and calmodulin kinase are required for endothelin-stimulated atrial natriuretic factor secretion from primary atrial myocytes. J Biol Chem 267 (1992) 5211-5216
16. 3 adenosine receptors. J Med Chem 37 (1994) 3614-3621
17. Kuhn M., Roltwick R., Baba H.A., Perriard J.C., Schmitz W., and Ehler E. Progressive cardiac hypertrophy and dysfunction in atrial natriuretic peptide (GC-A) deficient mice. Heart 87 (2002) 368-374
18. 1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure overload model. Circ Res 93 (2003) 759-766
19. 3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart. Cardiovasc Res 28 (1994) 1057-1061
20. Meyerhof W., Müller-Brechlin R., and Richter D. Molecular cloning of a novel putative G-protein coupled receptor expressed during rat spermiogenesis. FEBS Lett 284 (1991) 155-160
21. Morello S., Petrella A., Festa M., Popolo A., Monaco M., Vuttariello E., et al. Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation. Cancer Biol Ther 7 (2008) 278-284
22. Mubagwa K., and Flameng W. Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovasc Res 52 (2001) 25-39
23. Ohnishi A., Li P., Branch R.A., Biaggioni I.O., and Jackson E.K. Adenosine in renin-dependent renovascular hypertension. Hypertension 12 (1988) 152-161
24. Olah M.E., and Stiles G.L. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu Rev Pharmacol Toxicol 35 (1995) 581-606
25. 3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 268 (1993) 16887-16890
26. Reshkim S.J., Guerra L., Bagorda A., Debellis L., Cardone R., Li A.H., et al. Activation of A(3) adenosine receptor induces calcium entry and chloride secretion in A(6) cells. J Membr Biol 178 (2000) 103-113
27. Rongen G.A., Lenders J.W., Lambrou J., Willemsen J.J., Van Belle H., Thien T., et al. Presynaptic inhibition of norepinephrine release from sympathetic nerve endings by endogenous adenosine. Hypertension 27 (1996) 933-938
28. Salman H., Bergman M., Schlesinger H., Zahavi I., and Kessler-Icekson G. Adenosine stimulates ANP expression in cultured ventricular cardiomyocytes. J Cardiovasc Pharmacol 34 (1999) 7-9
29. Salvatore C.A., Tilley S.L., Latour A.M., Fletcher D.S., Koller B.H., and Jacobson M.A. Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells. J Biol Chem 275 (2000) 4429-4434
30. 3 adenosine receptor in cultured newborn rat cardiac myocytes. Cell Calcium 36 (2004) 387-396
31. Stowe D.F., O'Brien W.C., Chang D., Knop C.S., and Kampine J.P. Reversal of endothelin-induced vasoconstriction by endothelium-dependent and -independent vasodilators in isolated hearts and vascular rings. J Cardiovasc Pharmacol 29 (1997) 747-754
32. Tilley S.L., Wagoner V.A., Salvatore C.A., Jacobson M.A., and Koller B.H. Adenosine and inosine increase cutaneous vasopermeability by activating A(3) receptors on mast cells. J Clin Invest 105 (2000) 361-367
33. ATP channel activation. Cardiovasc Res 40 (1998) 138-145
34. 1 receptor subtype. Hypertension 46 (2005) 1381-1387
35. Yuan K., Cao C., Bai G.Y., Kim S.Z., and Kim S.H. Diadenosine tetraphosphate stimulates atrial ANP release via A(1) receptor: involvement of K(ATP) channel and PKC. Peptides 28 (2007) 1397-1405
36. 3 adenosine receptor in determining tissue levels of cAMP and blood pressure: studies in knock-out mice. Biochim Biophys Acta 1500 (2000) 280-290
37. ATP channel. J Mol Cell Cardiol 34 (2002) 263-277